Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;10(7):1419.
doi: 10.3390/jcm10071419.

Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease

Affiliations

Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease

Kazuki Ohashi et al. J Clin Med. .

Abstract

Although dual-energy X-ray absorptiometry (DXA) and body impedance analysis are commonly used to measure skeletal muscle mass (SMM), a computed tomography (CT) scan is preferred in clinical practice. We aimed to propose the cut-off values of skeletal muscle mass index (SMI) calculated using CT scans, using DXA as the reference method. We retrospectively assessed 589 patients with chronic liver disease. The SMI was assessed using appendicular SMM by DXA and total muscle area at the level of the third lumbar vertebra (L3) calculated by CT. The cut-off value was determined with reference to the Asian Working Group for Sarcopenia criteria. DXA identified 251 (42.6%) patients as having presarcopenia. In men, the cut-off value of SMI for presarcopenia was determined to be 45.471 cm2/m2, with an area under the curve (AUC) of 0.863 (95% confidence interval (CI): 0.823 to 0.903), and in women, this value was determined to be 35.170 cm2/m2, with an AUC of 0.846 (95% CI: 0.800 to 0.892). Cohen's kappa coefficient was 0.575 (95% CI: 0.485-0.665) in men and 0.539 (95% CI: 0.438-0.639) in women.

Keywords: computed tomography; dual-energy X-ray absorptiometry; sarcopenia; skeletal muscle mass.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Correlations between the SMI and ASMI in (A) men and (B) women. ASMI, appendicular skeletal muscle mass index; SMI, skeletal muscle mass index.
Figure 2
Figure 2
Mean differences of Z-scores (ASMI minus SMI) in (A) men and (B) women. Normality was examined using the Shapiro–Wilk test. ASMI, appendicular skeletal muscle mass index; SMI, skeletal muscle mass index; p, p-value.
Figure 3
Figure 3
Bland–Altman plot of muscle mass z-scores derived from the skeletal muscle mass index and appendicular skeletal muscle mass index. It represents 95% limits of agreement and 95% CIs between muscle mass z-scores derived from ASMI and SMI in (A) men and (B) women. ASMI, appendicular skeletal muscle mass index; SMI, skeletal muscle mass index; MD, mean differences; CI, confidence interval; UL, upper limit; LL, lower limit.
Figure 4
Figure 4
Receiver operating characteristic curves and the cut-off values for (A) men and (B) women. CI, confidence interval.

Similar articles

Cited by

References

    1. Chen L.K., Woo J., Assantachai P., Auyeung T.W., Chou M.Y., Iijima K., Jang H.C., Kang L., Kim M., Kim S., et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 2020;21:300–307. doi: 10.1016/j.jamda.2019.12.012. - DOI - PubMed
    1. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.P., Rolland Y., Schneider S.M., et al. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. - DOI - PMC - PubMed
    1. Cruz-Jentoft A.J., Bahat G., Bauer J., Boirie Y., Bruyère O., Cederholm T., Cooper C., Landi F., Rolland Y., Sayer A.A., et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi: 10.1093/ageing/afy169. - DOI - PMC - PubMed
    1. Chang K.V., Chen J.D., Wu W.T., Huang K.C., Hsu C.T., Han D.S. Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: A systematic review and meta-analysis. Liver Cancer. 2018;7:90–103. doi: 10.1159/000484950. - DOI - PMC - PubMed
    1. Bhanji R.A., Moctezuma-Velazquez C., Duarte-Rojo A., Ebadi M., Ghosh S., Rose C., Montano-Loza A.J. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol. Int. 2018;12:377–386. doi: 10.1007/s12072-018-9875-9. - DOI - PubMed

LinkOut - more resources